Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

3 structures for P58252

Entry ID Method Resolution Chain Position Source
7LS1 EM 330 A m 1-858 PDB
7LS2 EM 310 A m 1-858 PDB
AF-P58252-F1 Predicted AlphaFoldDB

54 variants for P58252

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3389114878 25 I>V No EVA
rs580943629 36 T>N No EVA
rs3400215813 43 A>G No EVA
rs585502790 50 R>G No EVA
rs1132570692 83 E>K No EVA
rs1133717694 88 F>C No EVA
rs1134550530 88 F>L No EVA
rs13460391 105 S>P No EVA
rs3389127594 106 P>Q No EVA
rs3389116489 120 R>G No EVA
rs3413120388 122 T>S No EVA
rs1133922698 126 L>P No EVA
rs3389117342 136 C>R No EVA
rs1134728916 141 T>I No EVA
rs3389121689 156 M>K No EVA
rs13460378 179 Q>R No EVA
rs3389117370 182 V>A No EVA
rs244383484 192 Y>D No EVA
rs1133227589 211 T>A No EVA
rs233030361 245 S>G No EVA
rs1134394463 247 A>T No EVA
rs3389104084 262 G>R No EVA
rs3389116484 269 A>T No EVA
rs3389117334 303 A>V No EVA
rs13460390 322 K>N No EVA
rs3389116409 335 L>F No EVA
rs3389116456 348 D>E No EVA
rs3389116525 368 R>L No EVA
rs3389104078 373 Y>* No EVA
rs3389058064 392 G>V No EVA
rs239718203 506 R>S No EVA
rs3389093850 521 V>M No EVA
rs3389118717 535 Q>* No EVA
rs3389116215 538 I>N No EVA
rs3389116369 588 N>D No EVA
rs3389121742 598 K>N No EVA
rs3401362533 611 D>E No EVA
rs3389104138 632 A>T No EVA
rs3389127633 641 W>C No EVA
rs3389121752 674 E>V No EVA
rs3389104097 678 S>N No EVA
rs1133198872 683 F>Y No EVA
rs3389108220 691 A>V No EVA
rs3389113039 695 E>V No EVA
rs3389121719 716 R>P No EVA
rs3389093849 741 M>K No EVA
rs3389113004 766 K>M No EVA
rs3389127575 768 G>A No EVA
rs3389108137 784 V>L No EVA
rs3389089422 789 P>H No EVA
rs1133723986 805 G>S No EVA
rs1135312781 806 G>S No EVA
rs1135032140 813 V>E No EVA
rs1132127764 826 D>V No EVA

No associated diseases with P58252

7 regional properties for P58252

Type Name Position InterPro Accession
domain Elongation factor EFG, domain V-like 739 - 828 IPR000640
domain Translational (tr)-type GTP-binding domain 17 - 362 IPR000795
domain Translation elongation factor EFTu-like, domain 2 411 - 485 IPR004161
domain Small GTP-binding protein domain 19 - 164 IPR005225
domain Translation elongation factor EFG/EF2, domain IV 621 - 737 IPR005517
conserved_site Tr-type G domain, conserved site 58 - 73 IPR031157
domain Elongation Factor G, domain II 503 - 564 IPR041095

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
  • Nucleus
  • Phosphorylation by CSK promotes cleavage and SUMOylation-dependent nuclear translocation of the C-terminal cleavage product
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

9 GO annotations of cellular component

Name Definition
aggresome An inclusion body formed by dynein-dependent retrograde transport of an aggregated protein on microtubules.
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
membrane raft Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
polysomal ribosome A ribosome bound to mRNA that forms part of a polysome.
polysome A multiribosomal structure representing a linear array of ribosomes held together by messenger RNA. They represent the active complexes in cellular protein synthesis and are able to incorporate amino acids into polypeptides both in vivo and in vitro.
ribonucleoprotein complex A macromolecular complex that contains both RNA and protein molecules.
synapse The junction between an axon of one neuron and a dendrite of another neuron, a muscle fiber or a glial cell. As the axon approaches the synapse it enlarges into a specialized structure, the presynaptic terminal bouton, which contains mitochondria and synaptic vesicles. At the tip of the terminal bouton is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic terminal bouton secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane.

9 GO annotations of molecular function

Name Definition
5S rRNA binding Binding to a 5S ribosomal RNA, the smallest RNA constituent of a ribosome.
actin filament binding Binding to an actin filament, also known as F-actin, a helical filamentous polymer of globular G-actin subunits.
GTP binding Binding to GTP, guanosine triphosphate.
GTPase activity Catalysis of the reaction: GTP + H2O = GDP + H+ + phosphate.
p53 binding Binding to one of the p53 family of proteins.
protein kinase binding Binding to a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
ribosome binding Binding to a ribosome.
RNA binding Binding to an RNA molecule or a portion thereof.
translation elongation factor activity Functions in chain elongation during polypeptide synthesis at the ribosome.

4 GO annotations of biological process

Name Definition
hematopoietic progenitor cell differentiation The process in which precursor cell type acquires the specialized features of a hematopoietic progenitor cell, a class of cell types including myeloid progenitor cells and lymphoid progenitor cells.
positive regulation of cytoplasmic translation Any process that activates or increases the frequency, rate or extent of cytoplasmic translation.
positive regulation of translation Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA or circRNA.
translational elongation The successive addition of amino acid residues to a nascent polypeptide chain during protein biosynthesis.

3 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P32324 EFT1 Elongation factor 2 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) PR
P13639 EEF2 Elongation factor 2 Homo sapiens (Human) PR
P05197 Eef2 Elongation factor 2 Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MVNFTVDQIR AIMDKKANIR NMSVIAHVDH GKSTLTDSLV CKAGIIASAR AGETRFTDTR
70 80 90 100 110 120
KDEQERCITI KSTAISLFYE LSENDLNFIK QSKDGSGFLI NLIDSPGHVD FSSEVTAALR
130 140 150 160 170 180
VTDGALVVVD CVSGVCVQTE TVLRQAIAER IKPVLMMNKM DRALLELQLE PEELYQTFQR
190 200 210 220 230 240
IVENVNVIIS TYGEGESGPM GNIMIDPVLG TVGFGSGLHG WAFTLKQFAE MYVAKFAAKG
250 260 270 280 290 300
EGQLSAAERA KKVEDMMKKL WGDRYFDPAN GKFSKSANSP DGKKLPRTFC QLILDPIFKV
310 320 330 340 350 360
FDAIMNFRKE ETAKLIEKLD IKLDSEDKDK EGKPLLKAVM RRWLPAGDAL LQMITIHLPS
370 380 390 400 410 420
PVTAQKYRCE LLYEGPPDDE AAMGIKSCDP KGPLMMYISK MVPTSDKGRF YAFGRVFSGV
430 440 450 460 470 480
VSTGLKVRIM GPNYTPGKKE DLYLKPIQRT ILMMGRYVEP IEDVPCGNIV GLVGVDQFLV
490 500 510 520 530 540
KTGTITTFEH AHNMRVMKFS VSPVVRVAVE AKNPADLPKL VEGLKRLAKS DPMVQCIIEE
550 560 570 580 590 600
SGEHIIAGAG ELHLEICLKD LEEDHACIPI KKSDPVVSYR ETVSEESNVL CLSKSPNKHN
610 620 630 640 650 660
RLYMKARPFP DGLAEDIDKG EVSARQELKA RARYLAEKYE WDVAEARKIW CFGPDGTGPN
670 680 690 700 710 720
ILTDITKGVQ YLNEIKDSVV AGFQWATKEG ALCEENMRGV RFDVHDVTLH ADAIHRGGGQ
730 740 750 760 770 780
IIPTARRCLY ASVLTAQPRL MEPIYLVEIQ CPEQVVGGIY GVLNRKRGHV FEESQVAGTP
790 800 810 820 830 840
MFVVKAYLPV NESFGFTADL RSNTGGQAFP QCVFDHWQIL PGDPFDNSSR PSQVVAETRK
850
RKGLKEGIPA LDNFLDKL